HomeANIX • NASDAQ
add
Anixa Biosciences Inc
Previous close
$3.38
Day range
$3.19 - $3.40
Year range
$2.07 - $4.20
Market cap
103.72M USD
Avg Volume
184.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 3.00M | -13.38% |
Net income | -2.79M | 11.12% |
Net profit margin | — | — |
Earnings per share | -0.09 | 10.00% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.60M | -32.88% |
Total assets | 16.98M | -30.29% |
Total liabilities | 2.07M | 16.74% |
Total equity | 14.91M | — |
Shares outstanding | 32.21M | — |
Price to book | 6.76 | — |
Return on assets | -41.84% | — |
Return on capital | -46.82% | — |
Cash Flow
Net change in cash
| (USD) | Apr 2025info | Y/Y change |
|---|---|---|
Net income | -2.79M | 11.12% |
Cash from operations | -1.50M | -3.23% |
Cash from investing | 2.34M | 321.22% |
Cash from financing | 18.00K | -97.99% |
Net change in cash | 857.00K | 28,666.67% |
Free cash flow | -730.88K | -70.02% |
About
Founded
1982
Headquarters
Website
Employees
5
